Supply Of 1) SRPHC82151025-GLYCOPYROLATE 0.5 MG + NEOSTIGMINE METHYL SULPHATE 2.5 MG INJ 5 ML , 2) SRPHC82151020-GLYCOPYRROLATE 0.2MG/ML INJ 1 ML , 3) SRPHC82185434-GLYCOPYRROLATE 25MCG INHALATION SOLUTION OF 1ML RESPULE S, 4) SRPHC82185450 GLYCOPYRR

Sharing tender

Supply Of 1) srphc82151025-glycopyrolate 0.5 mg + neostigmine methyl sulphate 2.5 mg inj 5 ml , 2) srphc82151020-glycopyrrolate 0.2mg/ml inj 1 ml , 3) srphc82185434-glycopyrrolate 25mcg inhalation solution of 1ml respule s, 4) srphc82185450 glycopyrrolate 9 mcg, for moterol 4.8 mcg and budesonide 160 mcg inhaler, 120 mdi canister & 5) srphc82185470-indacaterol 110 mcg + glycopyrronium 50 mcg cap , srphc82151020-glycopyrrolate 0.2mg/ml inj 1ml amp [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82151025-glycopyrolate 0.5 mg + neostigmine methylsulphate 2.5 mg inj 5 ml amp [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82185450-glycopyrrolate 9 mcg, formoterol 4.8 mcg and budesonide 160 mcg inh aler, 120 mdi canister [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82185470-indacaterol 110 mcg + glycopyrronium 50 mcg cap (one suitable device to be supplied for every 30 caps at free of cost) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] , srphc82185434-glycopyrrolate 25mcg inhalation solution of 1ml respule s [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ]